Central Nervous System News and Research

RSS

Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse

By studying a gene earlier linked to deafness in humans, researchers now have new insight into the molecular process by which components of the inner ear send messages to the brain.

20 Oct 2006

Toxic chemical found in 3 more medicines in Panama

A toxic chemical found in contaminated cough syrup suspected to have caused the deaths of 22 people in Panama, has now been found in three more medications made by a government-run factory in Panama.

19 Oct 2006

Researchers identifiy how immune system contributes to nerve fiber damage caused by multiple sclerosis

Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.

16 Oct 2006

Childhood cancer survivors more at risk of chronic health problems as adults

According to a new study adult survivors of childhood cancer can expect to suffer from one or more chronic health problems years after their cancer has been cured.

16 Oct 2006

Contaminated cough syrup kills 22 in Panama

The mysterious deaths of 22 people in Panama have now been linked to a contaminated cough syrup.

16 Oct 2006

Bayer forgot to tell risks of heart surgery drug

According to the German drug giant Bayer AG, the reason the company failed to inform U.S. regulators about a study on the risks of the heart-surgery drug Trasylol was a mistake.

2 Oct 2006

NIH to map genomic changes of lung, brain, and ovarian cancers

It is estimated that 174,470 new cases of lung cancer will be diagnosed in the United States in 2006. Lung cancer is the major cause of cancer-related mortality in both men and women, with an estimated 162,460 deaths expected to occur in 2006.

13 Sep 2006

Protection for nerve cells - eating up defective proteins

Nerve cells in the Central Nervous System can defend against and recover from damage by proteinlike clusters which are associated with neurodegenerative diseases such as Huntington's Chorea.

13 Sep 2006

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

A worldwide licensing arrangement for development, production and marketing of an antiepileptic drug created at the Hebrew University of Jerusalem has been signed by Shire Pharmaceuticals with Yissum, the Hebrew University's technology transfer company.

5 Sep 2006

Rheumatoid arthritis drugs appear to work better when delivered into the central nervous system

Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.

4 Sep 2006

Mature muscle fibers can revert to become cancerous

Mature muscle fibers, rather than their less-developed neighbors, are the tissues that turn malignant in a soft-tissue cancer that strikes children and teens, researchers at UT Southwestern Medical Center and Children's Medical Center Dallas have found.

4 Sep 2006

Scientists identify novel central nervous system proteins affected by chronic alcohol exposure

Researchers at the University at Buffalo studying the effects of alcohol on the brain, using zebrafish as a model, have identified several novel central nervous system proteins that are affected by chronic alcohol exposure.

31 Aug 2006

Boston Life Sciences announces issuance of U.S. patent for methods to diagnose ADHD

Boston Life Sciences has announced that the U.S. Patent and Trademark Office has issued a patent to the President and Fellows of Harvard College, the General Hospital Corporation and Organix that covers methods of diagnosing and monitoring attention deficit hyperactivity disorder (ADHD) by assessing the level of dopamine transporter (DAT) in at least one region of a patient's central nervous system.

14 Aug 2006